Bide Pharmatech Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 588.52 million compared to CNY 426.61 million a year ago. Revenue was CNY 588.52 million compared to CNY 426.61 million a year ago.

Net income was CNY 98.02 million compared to CNY 66.7 million a year ago. Basic earnings per share from continuing operations was CNY 1.4357 compared to CNY 1.0071 a year ago. Diluted earnings per share from continuing operations was CNY 1.4357 compared to CNY 1.0071 a year ago.